Back to dashboard
CommercialCoverageLow impact

Trogarzo ® (Ibalizumab-Uiyk)

UnitedHealthcare·Infectious Disease, Internal Medicine·Medical Benefit Drug Policy
Effective date
Jun 1, 2026
We identified it
Jun 2, 2026
Days to comply
—

Summary

Updated policy for Trogarzo (Ibalizumab-Uiyk), an HIV treatment drug covered under medical benefits. This policy update affects coverage criteria, prior authorization requirements, or billing procedures for this specialty medication used in multidrug-resistant HIV treatment.

Action Required

Action needed
By June 1, 2026: Billing team should review the updated Trogarzo policy bulletin at the provided URL to understand any changes to coverage criteria, prior authorization requirements, or billing procedures for this HIV medication. Update billing system and provider documentation requirements as specified in the full policy text.

Related policy hubs